Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study

scientific article

Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/JAC/47.1.43
P698PubMed publication ID11152430

P2093author name stringEriksson S
Norrby SR
Nord CE
Englund G
Myhre EB
Granström G
Wiström J
Svenungsson B
Lagergren L
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectinpatient careQ1431847
diarrheaQ40878
P304page(s)43-50
P577publication date2001-01-01
P1433published inJournal of Antimicrobial ChemotherapyQ6294770
P1476titleFrequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study
P478volume47

Reverse relations

cites work (P2860)
Q58798841A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in The Netherlands
Q28185605A randomized trial of yogurt for prevention of antibiotic-associated diarrhea
Q36864125A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients
Q40290996Activity of OPT-80, a novel macrocycle, compared with those of eight other agents against selected anaerobic species
Q37039028Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.
Q34984996Ageing and infection
Q89081593Antibiotic Resistance Characterization of Environmental E. coli Isolated from River Mula-Mutha, Pune District, India
Q44307285Antibiotic induced diarrhea and pseudomembranous colitis
Q91998180Antibiotic-Induced Increase in Inflammatory Markers in Cured Infectious Spondylitis : Two Case Reports
Q36108490Antibiotic-associated diarrhea and pseudomembranous colitis: are they less common with poorly absorbed antimicrobials?
Q37277087Antibiotic-associated diarrhea: epidemiology, trends and treatment
Q36446885Antibiotic-associated diarrhoea
Q40690828Antibiotic-associated diarrhoea in emergency department observation unit patients
Q55407461Antibiotic-induced changes in the microbiota disrupt redox dynamics in the gut.
Q85590502Antibiotica geassocieerde en Clostridium difficile geassocieerde diarree bij ouderen : Klinische les
Q44447065Antibiotics conspicuously affect community profiles and richness, but not the density of bacterial cells associated with mucosa in the large and small intestines of mice
Q42424817Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital
Q38588205Antimicrobial susceptibility testing breakpoints and methods from BSAC to EUCAST.
Q50025746Antimicrobial‐associated diarrhoea in three equine referral practices
Q51761741Are self-reported gastrointestinal symptoms among older adults associated with increased intestinal permeability and psychological distress?
Q85263911BSAC standardized disc susceptibility testing method (version 11)
Q97067608Bifidobacterium bifidum Suppresses Gut Inflammation Caused by Repeated Antibiotic Disturbance Without Recovering Gut Microbiome Diversity in Mice
Q42608467Characterization of a novel macrolide efflux gene, mef(B), found linked to sul3 in porcine Escherichia coli
Q24536057Clindamycin as an antimalarial drug: review of clinical trials
Q35759007Clindamycin plus quinine for treating uncomplicated falciparum malaria: a systematic review and meta-analysis
Q44778102Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem
Q36361044Clinical characteristics of Clostridium difficile infection in hospitalized patients with antibiotic-associated diarrhea in a university hospital in China
Q37032807Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infection
Q37401597Clinical use of probiotics in the pediatric population
Q39085710Clonal variation in high- and low-level phenotypic and genotypic mupirocin resistance of MRSA isolates in south-east London
Q92749601Clostridium butyricum Modulates the Microbiome to Protect Intestinal Barrier Function in Mice with Antibiotic-Induced Dysbiosis
Q38837137Clostridium difficile Enterocolitis and Reactive Arthritis: A Case Report and Review of the Literature
Q27016320Clostridium difficile Infection in Children: Current State and Unanswered Questions
Q34097514Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota
Q40923400Clostridium difficile in Crete, Greece: epidemiology, microbiology and clinical disease
Q36383006Clostridium difficile infection in hospitalized children in the United States
Q37289567Clostridium difficile infection in the twenty-first century
Q44509461Clostridium difficile infections related to antibiotic use and infection control facilities in two university hospitals
Q78518492Clostridium difficile-associated Enteric Disease
Q34767730Clostridium difficile-associated diarrhea: current strategies for diagnosis and therapy
Q26752760Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections
Q49195473Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).
Q38080794Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
Q37293859Does Lactobacillus GG prevent antibiotic-associated diarrhea in children?: Part A: Evidence-based answer and summary
Q38700972Dual-coated lactic acid bacteria: an emerging innovative technology in the field of probiotics
Q33938275Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice
Q35912695Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic clostridium difficile strains in the cecal contents of mice
Q41839829Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut model
Q34209418Effects of probiotics and antibiotics on the intestinal homeostasis in a computer controlled model of the large intestine
Q51743963Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study
Q35755346Efficacy of BIO K+ CL1285 in the reduction of antibiotic-associated diarrhea - a placebo controlled double-blind randomized, multi-center study
Q37112983Emerging Insights into Antibiotic-Associated Diarrhea and Clostridium difficile Infection through the Lens of Microbial Ecology
Q36885087Enteral-tube-feeding diarrhoea: manipulating the colonic microbiota with probiotics and prebiotics
Q33899721Epidemic Clostridium difficile strains demonstrate increased competitive fitness compared to nonepidemic isolates
Q24562996Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs
Q35922850Epidemiology and molecular characterization of Clostridium difficile strains from patients with diarrhea: low disease incidence and evidence of limited cross-infection in a Swedish teaching hospital
Q83853009Evaluating contemporary antibiotics as a risk factor for Clostridium difficile infection in surgical trauma patients
Q50794338Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics
Q36759245Extended antimicrobial prophylaxis after gastric cancer surgery: a systematic review and meta-analysis
Q35733944Factors influencing the development of antibiotic associated diarrhea in ED patients discharged home: risk of administering IV antibiotics
Q34823125Fosmidomycin, a novel chemotherapeutic agent for malaria
Q47856504Frequency of Antibiotic-Associated Diarrhea and Related Complications in Pediatric Patients Who Underwent Hypospadias Repair: a Comparative Study Using Probiotics vs Placebo
Q35134579Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis
Q28085584Gut microbiota as potential orchestrators of irritable bowel syndrome
Q36531406Hospital Transfer Network Structure as a Risk Factor for Clostridium difficile Infection
Q42136589Human intestinal microbiota gene risk factors for antibiotic-associated diarrhea: perspectives for prevention. Risk factors for antibiotic-associated diarrhea
Q98164075Identification of Simplified Microbial Communities That Inhibit Clostridioides difficile Infection through Dilution/Extinction
Q43828599Impact of hospital‐acquired Clostridium difficile
Q42261294In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile
Q55539731Infection Prophylaxis Update.
Q34761329Infection in the chronically critically ill: unique risk profile in a newly defined population
Q59442204Les diarrhées post-antibiotiques
Q36832446Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development
Q42778196Managing antibiotic associated diarrhoea
Q33222511Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea
Q38101378Metabolic plasticity for isoprenoid biosynthesis in bacteria
Q35862915Novel approaches to treating Clostridium difficile-associated colitis.
Q61307050Omadacycline Gut Microbiome Exposure Does Not Induce Clostridium difficile Proliferation or Toxin Production in a Model That Simulates the Proximal, Medial, and Distal Human Colon
Q40101500Pathogenicity Locus, Core Genome, and Accessory Gene Contributions to Clostridium difficile Virulence
Q28546491Patterns of Adverse Drug Reactions in Different Age Groups: Analysis of Spontaneous Reports by Community Pharmacists
Q33915343Postoperative Clostridium difficile-associated diarrhea
Q44663914Prevalence of diarrhea at a university hospital and association with modifiable risk factors
Q42631832Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections
Q38811781Probiotic approach to prevent antibiotic resistance.
Q39265808Probiotic treatment for the prevention of antibiotic-associated diarrhoea in geriatric patients: a multicentre randomised controlled pilot study
Q42470900Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials
Q46288228Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Outpatients-A Systematic Review and Meta-Analysis
Q91644124Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Q24186991Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Q24235039Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Q24245196Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Q24247364Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Q37892873Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection
Q35056944Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study
Q37286025Prophylactic antibiotics for clean, non-implant plastic surgery: what is the evidence?
Q44637882Pseudomembranous colitis during antibiotic therapy
Q38654043Randomized, Controlled, Crossover trial of Prevention of Clindamycin-Induced Gastrointestinal Signs Using a Synbiotic in Healthy Research Cats.
Q26767079Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection
Q37014790Rectal nitric oxide gas and stool cytokine levels during the course of infectious gastroenteritis
Q35199060Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile.
Q45324761Risk factors for seasonal influenza virus detection in stools of patients consulting in general practice for acute respiratory infections in France, 2014-2016.
Q34549108Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies
Q34094620Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis
Q38775801Role of antimicrobials in the treatment of adult patients presenting to the emergency department with acute gastroenteritis - A mini review.
Q38200538Role of doxycycline in Clostridium difficile infection acquisition
Q37355090Saccharomyces boulardii in childhood
Q28237525Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial
Q38376098Safety and Pharmacokinetic Study of Fidaxomicin in Children With Clostridium difficile-Associated Diarrhea: A Phase 2a Multicenter Clinical Trial
Q36909136Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem
Q36538752Safety, tolerance, and pharmacokinetic studies of OPT-80 in healthy volunteers following single and multiple oral doses
Q47149248Scientific Opinion on the substantiation of a health claim related to fermented milk containing Lactobacillus casei DN-114 001 plus yoghurt symbiosis (Actimel®), and reduction of Clostridium difficile toxins in the gut of patients receiving antibi...
Q35616704Severe acute diarrhea
Q37068231Stool therapy may become a preferred treatment of recurrentClostridium difficile?
Q64083709Surveys of parents and clinicians concerning the minimally important difference of probiotic therapy for prevention of paediatric antibiotic-associated diarrhoea
Q34565061Systematic review of antimicrobial drug prescribing in hospitals.
Q35771988Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults.
Q34487166Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea
Q37825531Systematic review: Clostridium difficile and inflammatory bowel disease.
Q90224285The Potential Impact of Probiotics on the Gut Microbiome of Athletes
Q28750385The changing epidemiology of Clostridium difficile infections
Q39182081The effect of polydextrose and probiotic lactobacilli in a Clostridium difficile-infected human colonic model
Q36066272The plastid-derived organelle of protozoan human parasites as a target of established and emerging drugs
Q35861325The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens
Q33927147Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile.
Q57779043Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics
Q40092648Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.
Q36373108Treatment of bacterial skin infections in ED observation units: factors influencing prescribing practice
Q37333236What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea?

Search more.